Sommaire

Numéro précédent | Numéro suivant

• • ·Safeguarding cancer care in a post-COVID-19 world

    Page :603

     
• • ·Cancer care for refugees: time to invest in people and systems

    Page :604-605

    André Ilbawi, Slim Slama

     
• • ·New opportunities in a challenging disease: lurbinectedin for relapsed small-cell lung cancer

    Page :605-607

    Oscar Arrieta, Zyanya Lucia Zatarain-Barrón, Andrés F Cardona

     
• • ·Non-small-cell lung cancer brain metastases and PD-(L)1 immune checkpoint inhibitors

    Page :607-608

    Fabrice Barlesi, Pascale Tomasini

     
• • ·The global imperative to make cancer medications affordable

    Page :609-610

    Nathan I Cherny, Elisabeth G E de Vries

     
• • ·FGFR inhibitors for advanced cholangiocarcinoma

    Page :610-612

    Tian Yang, Lei Liang, Ming-Da Wang, Feng Shen

     
• • ·Quality of life after breast-conserving surgery for women with non-low-risk ductal carcinoma in situ

    Page :612-614

    John R Benson

     
• • ·Platinum-sensitive ovarian cancer: liminal advances

    Page :614-615

    Richard T Penson

     
• • ·Expanding use of rucaparib as maintenance therapy in recurrent ovarian cancer: updates from the ARIEL3 trial

    Page :616-617

    Federica Tomao, Patrizia Vici, Silverio Tomao

     
• • ·Quality of life in patients with lung cancer: the way forward

    Page :617-619

    Maria Lucia Reale, Massimo Di Maio

     
• • ·The official French guidelines to protect patients with cancer against SARS-CoV-2 infection

    Page :619-621

    Benoit You, Alain Ravaud, Anne Canivet, Gérard Ganem, Philippe Giraud, Rosine Guimbaud, Laure Kaluzinski, Ivan Krakowski, Didier Mayeur, Thomas Grellety, Jean-Pierre Lotz

     
• • ·Preparedness for COVID-19 in the oncology community in Africa

    Page :621-622

    Verna Vanderpuye, Moawia Mohammed Ali Elhassan, Hannah Simonds

     
• • ·The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19

    Page :622-624

    The UK Coronavirus Cancer Monitoring Project team, Iris Anil, Roland Arnold, Sam Benkwitz-Beford, Simon Branford, Naomi Campton, Jean-Baptiste Cazier, Vinton Cheng, Helen Curley, Jamie D’Costa, Andrew Edmondson, Anshita Goel, Simon Hartley, Daniel J Hughes, Rachel Kerr, Alvin Lee, Lennard YW Lee, Naomi Longworth, Christopher Middleton, Gary Middleton, Piangfan Naksukpaiboon, Anna Olsson-Brown, Claire Palles, Karin Purshouse, Carol Sandys, Archana Sharma-Oates, Shivan Sivakumar, Ashley Smith, Thomas Starkey, Simon Thompson, Csilla Varnai

      
• • ·Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic

    Page :624-627

    Bruno H R de Paula, Indiara Araújo, Lívia Bandeira, Nathália M P B Barreto, Gary J Doherty

    
• • ·TAS-102 plus bevacizumab in metastatic colorectal cancer

    Page :e226

    Giuseppe A Colloca, Antonella Venturino

    
• • ·TAS-102 plus bevacizumab in metastatic colorectal cancer – Authors’ reply

    Page :e227

    Per Pfeiffer, Sören Möller, Stine Braendegaard Winther, Camilla Qvortrup

    
• • ·Hepatic metastases resection after cetuximab: are we missing something?

    Page :e228

    Ayhan Ulusakarya, Pasquale F Innominato, Mohamed Bouchahda, Francis A Levi, René Adam

    
• • ·Hepatic metastases resection after cetuximab: are we missing something? – Authors’ reply

    Page :e229

    Sian A Pugh, John A Bridgewater, John N Primrose, on behalf of the New EPOC investigators

    
• • ·Glioma patient-reported outcome assessment in clinical care

    Page :e230

    Constantin Tuleasca, Jonathan Knisely, Henri-Arthur Leroy, Andreas F Hottinger, Iulia Peciu-Florianu, Marc Levivier, Nicolas Reyns

    
• • ·Glioma patient-reported outcome assessment in clinical care – Authors’ reply

    Page :e231

    Terri S Armstrong, Susan M Chang, David Jenkinson, Paul Kluetz, Martin J B Taphoorn

    
• • ·Fulvestrant plus capivasertib for metastatic breast cancer

    Page :e232

    Tim Johannes Adrianus Dekker

    
• • ·Fulvestrant plus capivasertib for metastatic breast cancer

    Page :e233

    Ethan B Ludmir, Zachary R McCaw, Dae Hyun Kim, Lu Tian, Lee-Jen Wei

    
• • ·Fulvestrant plus capivasertib for metastatic breast cancer – Authors’ reply

    Page :e234

    Robert H Jones, Angela Casbard, Margherita Carucci, Andrew Foxley, Sacha J Howell

    
• • ·Challenges posed by COVID-19 to children with cancer

    Page :e235

    Rishi S Kotecha

    
• • ·Taking care of older patients with cancer in the context of COVID-19 pandemic

    Page :e236

    Loïc Mourey, Claire Falandry, Laure de Decker, Rabia Boulahssass, Elisabeth Carola, Leila Bengrine Lefevre, Tristan Cudennec, Etienne Brain, Eléna Paillaud, Pierre Soubeyran

    
• • ·Preparing African anticancer centres in the COVID-19 outbreak

    Page :e237

    Amine Souadka, Amine Benkabbou, Brahim Al Ahmadi, Saber Boutayeb, Mohammed Anass Majbar

    
• • ·Cancer care in the time of COVID-19

    Page :628

    Talha Khan Burki

     
• • ·Cancer guidelines during the COVID-19 pandemic

    Page :629-630

    Talha Khan Burki

     
• • ·Lack of protective gear disrupts oncology care

    Page :631-632

    Roxanne Nelson

    Plan Plan  
• • ·COVID-19: impact on cancer workforce and delivery of care

    Page :633

    Susan Mayor

     
• • ·New therapy for children with plexiform neurofibromas

    Page :e238

    Elizabeth Gourd

     
• • ·CAR T-cell therapy for relapsed or refractory mantle-cell lymphoma

    Page :e239

    Robert Stirrups

     
• • ·Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan

    Page :634-636

    Heng Mei, Xiaorong Dong, Yadan Wang, Liang Tang, Yu Hu

     
• • ·The economic burden of cancer care for Syrian refugees: a population-based modelling study

    Page :637-644

    Rima A Abdul-Khalek, Ping Guo, Forbes Sharp, Adrian Gheorghe, Omar Shamieh, Tezer Kutluk, Fouad Fouad, Adam Coutts, Ajay Aggarwal, Deborah Mukherji, Ghassan Abu-Sittah, Kalipso Chalkidou, Richard Sullivan, R4HC-MENA collaboration

    Résumé Résumé Plan Plan  
• • ·Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

    Page :645-654

    José Trigo, Vivek Subbiah, Benjamin Besse, Victor Moreno, Rafael López, María Angeles Sala, Solange Peters, Santiago Ponce, Cristian Fernández, Vicente Alfaro, Javier Gómez, Carmen Kahatt, Ali Zeaiter, Khalil Zaman, Valentina Boni, Jennifer Arrondeau, Maite Martínez, Jean-Pierre Delord, Ahmad Awada, Rebecca Kristeleit, Maria Eugenia Olmedo, Luciano Wannesson, Javier Valdivia, María Jesús Rubio, Antonio Anton, John Sarantopoulos, Sant P Chawla, Joaquín Mosquera-Martinez, Manolo D’Arcangelo, Armando Santoro, Victor M Villalobos, Jacob Sands, Luis Paz-Ares

    Résumé Résumé Plan Plan   
• • ·Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

    Page :655-663

    Sarah B Goldberg, Kurt A Schalper, Scott N Gettinger, Amit Mahajan, Roy S Herbst, Anne C Chiang, Rogerio Lilenbaum, Frederick H Wilson, Sacit Bulent Omay, James B Yu, Lucia Jilaveanu, Thuy Tran, Kira Pavlik, Elin Rowen, Heather Gerrish, Annette Komlo, Richa Gupta, Hailey Wyatt, Matthew Ribeiro, Yuval Kluger, Geyu Zhou, Wei Wei, Veronica L Chiang, Harriet M Kluger

    Résumé Résumé Plan Plan   
• • ·Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis

    Page :664-670

    Kerstin N Vokinger, Thomas J Hwang, Thomas Grischott, Sophie Reichert, Ariadna Tibau, Thomas Rosemann, Aaron S Kesselheim

    Résumé Résumé Plan Plan  
• • ·Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

    Page :671-684

    Ghassan K Abou-Alfa, Vaibhav Sahai, Antoine Hollebecque, Gina Vaccaro, Davide Melisi, Raed Al-Rajabi, Andrew S Paulson, Mitesh J Borad, David Gallinson, Adrian G Murphy, Do-Youn Oh, Efrat Dotan, Daniel V Catenacci, Eric Van Cutsem, Tao Ji, Christine F Lihou, Huiling Zhen, Luis Féliz, Arndt Vogel

    Résumé Résumé Plan Plan   
• • ·Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial

    Page :685-698

    Madeleine T King, Emma K Link, Tim J Whelan, Ivo A Olivotto, Ian Kunkler, Antonia Helen Westenberg, Guenther Gruber, Penny Schofield, Boon H Chua, BIG 3-07/TROG 07.01 trial investigators, Boon H Chua, Claire Phillips, Guy Bryant, Helen Westenberg, Om Pra-Kesh Purohit, Verity Ahern, Peter Graham, Mohamed Akra, Orla McArdle, Peter O’Brien, Jane Ludbrook, Jennifer Harvey, John H Maduro, Isabelle Gabelle-Flandin, Carine Kirkove, Carolyn Bedi, Joseph Martin, Tony Vu, Theirry Muanza, Anthony Neal, Adel Courdi, Juliette Thariat, Eileen Rakovitch, Laurien Daniels, Marjan van Hezewijk, Wlasyslawa Cwajna, Adelheid Roelstraete, Angela van Baardwijk, Nicola Russel, Anne Koch, Jennifer Croke, Imogen Locke, Peter Jeal, Quenten Walker, Kandeepeepan Thuraisingham, Anupam Chauduri, David Joseph, Mandy Taylor, Sabine Vanderkam, Tony Woo, Johann Tang, Michael Yassa, Elaine Wai, Susan Hewitt, Shazia Mahmood, Jennifer Gilmore, Bolante Ofi, Amit Bahl, Olga Vujovic, Edward Yu, Duc Le, Iwa Kong, Alan Nichol, Nina Bijker, Geoff Delaney, Malcolm Feigen, Adeline Lim, Michael Chao, Margaret Latham, Hafiz Algurafi, Christoph Tausch, Eric Khoo, Sam Leung, Karen Taylor, Sasha Senthi, Andrea Stevens, Abhro Chaudhuri, Susan Cleator, Adrian Murray Brunt, Scott Babington, David Christie, Daniel Zwahlen, Ulrich Schratzenstaller, Laurence Masson, Nicola Storey, Eshwar Kumar, Liz Sherwin, Reinhilde Weytjens, Sharma Ravi, Patricia Lawton, Ruth Angell, Glenys Round, Angela Allen, Ziad Thotathil, Margaret Anthes, Christiane Reuter, Laura Pettit, Laura Pettit, Yvonne Zissiadis, Christine Elder, Antoinette Verbeek-de Kanter, Andree Lirette, Ludwig Plasswilm, David Spooner, Fiona Hoar, Islam Mohamed, Kristina Lossl, Vivienne Loo, Antonella Richetti, Tamasin Evans, Aisling Hennessy, Medhat El-Mallah, Marketa Skala, Raef Awad, Isabelle Germain, Carine Mitine, Hilde Van Parijs, Mark Churn, Nawaz Walji, Michael Francis, Karin Stellamans, Gunther Gruber, Giovanni Ivaldi, Abdulla Alhasso, Lizbeth Kenny, Ken Tiver, Matthew Griffin, Gillian Lamoury, Marco Trovo, Hafiz Algufarfi, Nawaz Walji, Minjae Lah, David Christie, Abdulla Alhasso, Scott Carruthers, George Papadatos, Gabriel Paardekooper, Abhro Chaudhuri, Mojca Persic, Bernadette Lavery

    Résumé Résumé Plan Plan   
• • ·Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

    Page :699-709

    Jacobus Pfisterer, Catherine M Shannon, Klaus Baumann, Joern Rau, Philipp Harter, Florence Joly, Jalid Sehouli, Ulrich Canzler, Barbara Schmalfeldt, Andrew P Dean, Alexander Hein, Alain G Zeimet, Lars C Hanker, Thierry Petit, Frederik Marmé, Ahmed El-Balat, Rosalind Glasspool, Nikolaus de Gregorio, Sven Mahner, Tarek M Meniawy, Tjoung-Won Park-Simon, Marie-Ange Mouret-Reynier, Cristina Costan, Werner Meier, Alexander Reinthaller, Jeffrey C Goh, Tifenn L’Haridon, Sally Baron Hay, Stefan Kommoss, Andreas du Bois, Jean-Emmanuel Kurtz, AGO-OVAR 2.21/ENGOT-ov 18 Investigators, Sven Ackermann, Christoph Anthuber, Mustafa Aydogdu, Angelika Baldauf, Wolfgang Bauer, Dirk Behringer, Antje Belau, Alexandra Bender, Cosima Brucker, Alexander Burges, Ulrich Canzler, Trygve Daabach, Dominik Denschlag, Mustafa Deryal, Steffen Dörfel, Juliane Ebert, Ahmed El-Balat, Tanja Fehm, Susanne Maria Feidicker, Gabriele Feisel-Schwickardi, Ricardo Felberbaum, Matthias Frank, Gerhard Gebauer, Bernd Gerber, Axel Gerhardt, Andrea Grafe, Martin Griesshammer, Eva-Maria Grischke, Isolde Gröll, Martina Gropp-Meier, Dietrich Hager, Volker Hanf, Carla Verena Hannig, Peer Hantschmann, Philipp Harter, Tanja Hauzenberger, Uwe Herwig, Martin Heubner, Carsten Hielscher, Felix Hilpert, Thomas Hitschold, Manfred Hofmann, Christian Jackisch, Wolfgang Janni, Ludwig Kiesel, Yon-Dschun Ko, Hans-Joachim Koch, Petra Krabisch, Peter Krieger, Thomas Kubin, Thorsten Kühn, Björn Lampe, Peter Ledwon, Sabine Lemster, Benno Lex, Clemens Liebrich, Ralf Lorenz, Hans-Joachim Lück, Sven Mahner, Peter Mallmann, Frederik Marmé, Werner Meier, Wolfgang Meinerz, Götz Menke, Volker Möbus, Thomas Müller, Volker Müller, Tanja Neunhöffer, Angelika Ober, Gülten Oskay-Özcelik, Horst Ostertag, Tjoung-Won Park-Simon, Martin Pölcher, Beate Rautenberg, Daniel Rein, Wilhelm Reiter, Andreas Rempen, Ingo Runnebaum, Barbara Schmalfeldt, Marcus Schmidt, Sabine Schnohr, Heinz Scholz, Willibald Schröder, Jalid Sehouli, Eike Simon, Antje Sperfeld, Annette Steckkönig, Hans-Georg Strauß, Ronaldo Stuth, Jürgen Terhaag, Falk Thiel, Marc Thill, Oliver Tomé, Christoph Uleer, Susanne Vogel, Hermann Voß, Michael Weigel, Ulrich Winkler, Arthur Wischnik, Tobias Zeiser, Andreas Zorr, Ros Glasspool, Emma Hudson, Rachel Jones, Judith Lafleur, Christian Marth, Edgar Petru, Alexander Reinthaller, Yoland Antill, Mary Azer, Sally Baron-Hay, Philip Beale, Stephen Begbie, Allison Black, Karen Briscoe, Andrew Dean, Jeffrey Goh, Sandra Harvey, Chee Lee, Marco Matos, Tarek Meniawy, Inger Olesen, Catherine Shannon, Paul Vasey, Sophie Abadie-Lacourtoisie, Olivier Arsene, Sophie Barthier, Célia Becuwe-Roemer, Dominique Berton-Rigaud, Maria Cappiello-Bataller, Stéphanie Catala, Cristina Costan, Francesco Del Piano, Gaël Deplanque, Raymond Despax, Nadine Dohollou, Claire Garnier-Tixidré, Julien Grenier, Emmanuel Guardiola, Anne-Claire Hardy-Bessard, Florence Joly, Jean-Emmanuel Kurtz, Claudia Lefeuvre-Plesse, Marianne Leheurteur, Anne Lesoin, Charles-Briac Levache, Tifenn L’Haridon, Raffaele Longo, Alain Lortholary, Jérôme Meunier, Marie-Ange Mouret-Reynier, Thierry Petit, Nadia Raban, Olivier Romano, Jean-Michel Vannetzel, Alain Zannetti

    Résumé Résumé Plan Plan   
• • ·Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial

    Page :710-722

    Jonathan A Ledermann, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew R Clamp, Giovanni Scambia, Alexandra Leary, Robert W Holloway, Margarita Amenedo Gancedo, Peter C Fong, Jeffrey C Goh, David M O’Malley, Deborah K Armstrong, Susana Banerjee, Jesus García-Donas, Elizabeth M Swisher, Terri Cameron, Lara Maloney, Sandra Goble, Robert L Coleman

    Résumé Résumé Plan Plan   
• • ·Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study

    Page :723-732

    Michael Koller, Omar Shamieh, Marianne J Hjermstad, Kjersti Hornslien, Teresa Young, Tara Chalk, Georgios Ioannidis, Amelie Harle, Colin D Johnson, Krzysztof A Tomaszewski, Samantha Serpentini, Monica Pinto, Lotte van der Weijst, Annelies Janssens, Ofir Morag, Wei-Chu Chie, Juan I Arraras, Cecilia Pompili, Wolfgang Jungraithmayr, Marlene Hechtner, Despina Katsochi, Karolina Müller, Laura Gräfenstein, Christian Schulz, Andrew Bottomley, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, EORTC Lung Cancer Group, European Society of Thoracic Surgeons

    Résumé Résumé Plan Plan  
• • ·The increasing value of eHealth in the delivery of patient-centred cancer care

    Page :e240

    Frank J Penedo, Laura B Oswald, Joshua P Kronenfeld, Sofia F Garcia, David Cella, Betina Yanez

    Résumé Résumé Plan Plan   
• • ·Outcome measures in multimodal rectal cancer trials

    Page :e252

    Emmanouil Fokas, Robert Glynne-Jones, Ane Appelt, Regina Beets-Tan, Geerard Beets, Karin Haustermans, Corrie Marijnen, Bruce D Minsky, Ethan Ludmir, Phil Quirke, David Sebag-Montefiore, Julio Garcia-Aguilar, Maria Antonietta Gambacorta, Vincenzo Valentini, Marc Buyse, Claus Rödel

    Résumé Résumé Plan Plan   
• • ·Clinical implications of food–drug interactions with small-molecule kinase inhibitors

    Page :e265

    G D Marijn Veerman, Koen G A M Hussaarts, Frank G A Jansman, Stijn W L Koolen, Roelof W F van Leeuwen, Ron H J Mathijssen

    Résumé Résumé Plan Plan  
• • ·Cancer in Syrian refugees in Jordan and Lebanon between 2015 and 2017

    Page :e280

    Paul B Spiegel, Joseph G Cheaib, Saad Abdel Aziz, Orit Abrahim, Michael Woodman, Adam Khalifa, Minyoung Jang, Farrah J Mateen

    Résumé Résumé Plan Plan  
• • ·Cutaneous metastasis of renal cell carcinoma

    Page :e292

    Han Jie Lee, Alvin Lee, Darren Tan, Jingzeng Du, Yuehan Wang, Po Yin Tang, Allen Soon Phang Sim